IBTK and neoplasm: The median age of tumor onset was 65 days for Ibtk+/+Eμ-myc and 120 days for Ibtk−/−Eμ-myc mice, indicating a statistically significant delay of lymphomagenesis in absence of Ibtk (p < 0.0001) (Fig. 1b).